Wilson WH - Search Results

1

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.

Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM. Davis RE, et al. Among authors: wilson wh. Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638. Nature. 2010. PMID: 20054396 Free PMC article.

2

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wilson WH, Chabner BA, Bryant G, Bates S, Fojo A, Regis J, Jaffe ES, Steinberg SM, Goldspiel BR, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1995 Feb;13(2):381-6. doi: 10.1200/JCO.1995.13.2.381. J Clin Oncol. 1995. PMID: 7531220 Clinical Trial.

3

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wilson WH, Bates SE, Fojo A, Bryant G, Zhan Z, Regis J, Wittes RE, Jaffe ES, Steinberg SM, Herdt J, et al. Wilson WH, et al. J Clin Oncol. 1995 Aug;13(8):1995-2004. doi: 10.1200/JCO.1995.13.8.1995. J Clin Oncol. 1995. PMID: 7636540 Clinical Trial.

4

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, et al. Wilson WH, et al. J Clin Oncol. 1993 Aug;11(8):1573-82. doi: 10.1200/JCO.1993.11.8.1573. J Clin Oncol. 1993. PMID: 7687667 Clinical Trial.

5

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.

Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Wilson WH, et al. Blood. 1996 Jun 1;87(11):4531-7. Blood. 1996. PMID: 8639820 Free article.

6

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.

Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M. Wilson WH, et al. Blood. 1997 Jan 15;89(2):601-9. Blood. 1997. PMID: 9002964 Free article.

7

The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease.

Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wilson WH, Longo DL, Tosato G. Teruya-Feldstein J, et al. Among authors: wilson wh. Blood. 1997 Nov 15;90(10):4099-105. Blood. 1997. PMID: 9354680 Free article.

8

Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications.

Jaffe ES, Wilson WH. Jaffe ES, et al. Among authors: wilson wh. Cancer Surv. 1997;30:233-48. Cancer Surv. 1997. PMID: 9547995 Review.

9

Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas.

Wilson WH, Little R, Pearson D, Jaffe ES, Steinberg SM, Cheson BD, Humphrey R, Kohler DR, Elwood P. Wilson WH, et al. J Clin Oncol. 1998 Jul;16(7):2345-51. doi: 10.1200/JCO.1998.16.7.2345. J Clin Oncol. 1998. PMID: 9667249 Clinical Trial.

10

CNS involvement in primary mediastinal large B-cell lymphoma.

Bishop PC, Wilson WH, Pearson D, Janik J, Jaffe ES, Elwood PC. Bishop PC, et al. Among authors: wilson wh. J Clin Oncol. 1999 Aug;17(8):2479-85. doi: 10.1200/JCO.1999.17.8.2479. J Clin Oncol. 1999. PMID: 10561312 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

547 results

Search Page